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dependency and 2% high dependency. In general, our
sample population had a good general knowledge and
understanding of tobacco use (number of premature
deaths per year, percentage of smokers in France, cost of
tobacco for health insurance). Average daily tobacco
expenses were €2.3 (roughly corresponding to an aver-
age consumption of 10 cigarettes/day), and the subjects
declared themselves ready to pay around €83 to stop
smoking (€157 in older adults). This ﬁgure is relatively
low and is explained without doubt by an underestima-
tion of the potential risks of tobacco dependency. CON-
CLUSION: Young people are a population whose
dependency level is mainly low or moderate, a fact that
enables—with appropriate but generalised mobilization
(doctor, educator, pharmacist, family)—a smoking cessa-
tion attempt to succeed.
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A Health care program involves many dimensions, 
and its appraisal requires multicriteria decision analysis. 
This applies to new organisations for Health care deliv-
ery set up in France as “co-ordinated networks”. Their
objectives are to combine health and social care inter-
ventions in a structured framework, in hospital and out-
patient settings in order to optimise Health care services.
The Health care network “Quietude” was set in Paris for
out-patient palliative care: to permit termination phase
patients to die at home, to optimise symptoms care and
hospitalisation, and to keep patients’ families informed
about care, medications, and administrative procedures.
OBJECTIVE: To evaluate several dimensions of the
“Quietude” network, medical care, organisation, pa-
tients, professionals and families satisfaction, and eco-
nomic impact. METHODS: Qualitative and quantitative
studies were based on interviews, questionnaires, Delphi
panels, and data currently collected through the network
ITS (N patient’s = 435). RESULTS: Mean LOS is 40 days,
and mean Health care cost per day is €190. Ambulatory
care represents 80%, medication 15.5% and coordina-
tion 4.5%. Quality of care is considered as satisfactory
by 94% of families and professionals. Over 95% of the
professionals think pain and symptoms treatments are
completely managed compared to 80% of families. Other
discrepancies in perception are observed in emergency
management, (92% vs. 68%), hospitalisation planning
(92% vs. 75%), continuity of care (95% vs. 80%), and
administrative information access (79% vs. 70%). A total
of 75% of professionals think patients’ wishes for the
location of their death were respected. Needs for improv-
ing population targeting and ITS were identiﬁed. CON-
CLUSIONS: Most objectives set by “Quietude” with
regard to the Health care resources commonly employed
during the last months of life were achieved to the beneﬁt
of patients, professionals, and families at a very low 
coordination cost. Multicriteria analysis is particularly
adapted to an appraisal of this type of innovative Health
care provision.
PHP37
USING PATIENT REPORTED OUTCOMES (PRO)
DATA TO SEGMENT HEALTH CARE
CONSUMERS AND UNCOVER THEIR
RECEPTIVENESS TO PHARMACEUTICAL
ADVERTISING
Edmondson M, McDonnell D
Consumer Health Sciences, Princeton, NJ, USA
OBJECTIVES: Understanding how to develop marketing
messages for Health care consumers presents a constant
challenge for pharmaceutical companies. By using patient
reported outcomes data, the objective of this study was
to segment the various types of Health care consumers
and uncover each group’s receptiveness to pharmaceuti-
cal advertising. METHODS: An annual, self-reported
study of U.S. consumer attitudes and behaviors was
ﬁelded in June 2002 and included 30,213 adult respon-
dents. We stratiﬁed and weighted the sample by key
demographics. We then conducted a cluster analysis on
20 Health care opinions designed to evaluate health-
related compliance and proactivity. RESULTS: Health
care consumers segmented into ﬁve clusters based on a
variety of patient reported outcomes: attitudes, opinions,
demographics, and Health care resource use. Brand
Believers (22% or 44.5 Million) endorse the brand con-
tract and are most receptive to marketing efforts. Rock-
wellians (24% or 49 Million) are driven by trust and
value the relationship with their physician. What-Me
Worry? (18% or 37.2 Million) are quite conﬁdent in their
ability to obtain the appropriate Health care. Young and
Angry (18% or 36.5 Million) have been let down in
someway by the Health care system. Novice Nellies (18%
or 36.8 Million) require training to interpret Health care
messages. CONCLUSIONS: Patient reported outcomes
data can assist pharmaceutical companies proﬁle and
understand each consumer segment. This analysis reveals
that two speciﬁc segments (Brand Believers and Rock-
wellian) or 93.5 Million U.S. consumers are more recep-
tive to pharmaceutical marketing efforts than the other
three segments. Further analysis of these two consumer
segments within a speciﬁc therapeutic condition would
yield additional insight into the attitudes and behaviors
of each group.
